Pete Govorchin

Pete Govorchin

President, City of Hope Chicago

Pete Govorchin, MBA, is president of City of Hope® Cancer Center Chicago, where he oversees a team of physicians, clinical providers and administrative professionals who are committed to providing patients in Chicagoland with access to leading-edge cancer care and innovative treatment options. A recognized community leader and longtime advocate for improving health care equity in Illinois and beyond, Govorchin has pioneered multiple projects with community and industry partners to boost access to high-quality care for people diagnosed with cancer.

Prior to taking on the role of president, Govorchin was chief operating officer (COO) for Cancer Treatment Centers of America (CTCA)—a nationwide cancer center that merged with City of Hope in 2022. In 2024, Govorchin was named a Crain’s Notable Leader in Health Care  for his role in managing the merger of CTCA’s existing locations with City of Hope’s national network and for his work in the field of community outreach and health equity.

As COO, Govorchin oversaw the organization’s national expansion strategy and oversaw additional locations in Downtown Chicago and the North Shore. His responsibilities also included talent acquisition, business development, finance and operations. One of his most significant achievements was broadening access to cancer treatment by successfully negotiating the inclusion of five Illinois Medicaid plans, reinforcing City of Hope’s commitment to equity.

A board member for many community and advocacy organizations—including the Josselyn Center, which provides accessible mental health services in 300 communities; Access Lake, which is being designed to coordinate specialty care in Lake County; the Libertyville Rotary Club; and the American College of Healthcare Executives—Govorchin was also a key leader in the creation of both the Illinois Cancer Care is Different Coalition and the Illinois Cancer Patient Bill of Rights, which champion early detection and equitable access to innovative cancer treatments. He earned his undergraduate degree at Grand Valley State University in Michigan and his MBA at Loyola University of Chicago.